Financial Risk Evaluation And Control Of HZ Pharmaceutical Industry

At present,China is in the initial stage of the 14 th Five-year Plan,and its science,technology and economic strength are constantly improving and showing a positive development trend.At the same time,it is undeniable that China and even the world are facing great challenges brought by the epidemic.In this context,the pressure of competition in China’s pharmaceutical manufacturing industry is increasing.In the daily production and market competition of enterprises,financial risk,as an important economic signal,provides indispensable reference information for enterprise managers to timely respond to the industry conditions,which includes the financial status,operation status and profitability of enterprises.Financial risks may exist in every link of production,operation and daily management of an enterprise.The process of risk discovery,risk analysis and risk response is conducive to the operation and operation of HZ Pharmaceutical and the improvement of enterprise competitiveness.In this paper,HZ Pharmaceutical,which has a certain scale and complicated sales links in the industry,is selected as the research subject,and the research method combining data and factor analysis is used to carry out the evaluation and control research.First of all,a comprehensive review is made on the research background,the purpose and significance of the topic as well as the domestic and foreign literature referred to,and a brief exposition is made on the scientific theoretical basis and objective methods related to financial risk.Secondly,according to the financial data released by HZ Pharmaceutical in recent years,it identifies the current and potential financing,investment,operation,income distribution and cash flow risks of the company from five financial risk perspectives.Thirdly,the factor analysis method was used to establish the corresponding horizontal and vertical risk evaluation models for the identified risks of HZ Pharmaceutical,which was used as the basis for the establishment of the control system.The analysis results show that HZ Pharmaceutical is faced with great financial cost pressure,reduced liquidity capacity caused by overstocking of inventory,poor capital turnover in the production link,and continuous decline in net cash flow caused by unreasonable capital planning.Finally,reasonable countermeasures are proposed for the related problems found in the previous paper,so as to weaken the damage caused by financial risks to the company’s operation as much as possible,and strive to optimize the company’s financial status and production efficiency as a whole,so as to achieve the sound development of the company in the future.